Document Type : original article


1 Assistant Professor of obstetrics & Gynecology, Fellowship of infertility, Supporting the family and the youth of population Research Core, Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

2 Clinical Research Development Unit of Akbar Hospital, Department of Pediatrics, School of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran

3 Student of medical science, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

4 Student of medical science, Faculty of Medicine, Mashhad University of Medical Sciences

5 MD, Mashhad University of Medical Sciences, Mashhad, Iran.


Background: Since its announcement as a pandemic, COVID-19 has been shown to be associated with more severe outcomes among pregnant women. Infected mothers may develop Intrauterine Growth Retardation (IUGR), stillbirth, premature labor, and Disseminated Intravascular Coagulation when carrying a child (DIC). The present study aimed to estimate the risk of severe COVID-19 and its correlation with adverse neonatal outcomes among pregnant women.
Methods: This was a population-based, retrospective cohort study of all pregnancies with a live birth or fetal death in Mashhad, Iran, from February 20, 2020, to June 21, 2020, on 460 patients who tested positive for COVID-19. The assessed neonatal outcomes included preterm birth, IUGR, stillbirth, severe neonatal asphyxia, and neonatal death. Modified Poisson and multinomial logistic regression models were used to derive relative risk estimates.
Results: 460 patients identified with COVID-19 during pregnancy were assessed in the study. Overall, the most prevalent complication was preterm birth, with a total of 119 (25.9) cases. In multivariable analysis, the risk of preterm labor, low birth weight, severe neonatal asphyxia, ICU-admitted mother, the length of hospitalization> 7 days and IUGR were significantly increased in the Stillbirth. The risk of global preterm birth had also significantly increased in the Stillbirth group compared to the other group (91.7% versus 23.7%, aOR = 3.66, 95% CI [8.85- 165.87], p < 0.001).
Conclusion: Along with the possibility of more severe COVID-19 infection among pregnant women, five complicated outcomes were described in the present study, including preterm birth, IUGR, stillbirth, severe neonatal asphyxia, and neonatal deaths as risk factors of COVID-19 infection in pregnancy.


  1. Abedzadeh-Kalahroudi M, Sehat M, Vahedpour Z, Talebian P, Haghighi AJTJoO, Gynecology. Clinical and obstetric characteristics of pregnant women with Covid-19: A case series study on 26 patients. 2021; 60(3):458-62.
  2. Lokken EM, Walker CL, Delaney S, Kachikis A, Kretzer NM, Erickson A, Resnick R, Vanderhoeven J, Hwang JK, Barnhart N, Rah J, McCartney SA, Ma KK, Huebner EM, Thomas C, Sheng JS, Paek BW, Retzlaff K, Kline CR, Munson J, Blain M, LaCourse SM, Deutsch G, Adams Waldorf KM. Clinical characteristics of 46 pregnant women with a severe acute respiratory syndrome coronavirus 2 infection in Washington State. 2020; 223(6):911. e1- e14.
  3. Jafari M, Pormohammad A, Sheikh Neshin SA, Ghorbani S, Bose D, Alimohammadi S, Basirjafari S, Mohammadi M, Rasmussen-Ivey C, Razizadeh MH, Nouri-Vaskeh M, Zarei M. Clinical characteristics and outcomes of pregnant women with COVID‐19 and comparison with control patients: A systematic review and meta‐analysis. 2021; 31(5):1-16.
  4. Blandenier E, Habibi Z, Kousi T, Sestito P, Flahault A, Rozanova L. Initial COVID-19 outbreak: an epidemiological and socioeconomic case review of Iran. 2020; 17(24):9593.
  5. Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne. 2021; 193(16):E540-e8.
  6. Khalil A, Kalafat E, Benlioglu C, O'Brien P, Morris E, Draycott T, Thangaratinam S, Doare KL, Heath P, Ladhani S, Dadelszen Pv, Magee LA. SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes. 2020; 25:100446.
  7. Mirbeyk M, Saghazadeh A, Rezaei NJAog, obstetrics. A systematic review of pregnant women with COVID-19 and their neonates. 2021; 304:5-38.
  8. Meyyazhagan A, Pushparaj K, Balasubramanian B, Kuchi Bhotla H, Pappusamy M, Arumugam VA, Easwaran M, Pottail L, Mani P, Tsibizova V, Renzo GCD. COVID‐19 in pregnant women and children: Insights on clinical manifestations, complexities, and pathogenesis. 2022; 156(2):216-24.
  9. Quinn J-A, Munoz FM, Gonik B, Frau L, Cutland C, Mallett-Moore T, Kissou A, Wittke F, Das M, Nunes T, Pye S, Watson W, Alguacil Ramos AM, Cordero JF, Huang WT, Kochhar S, Buttery J; Brighton Collaboration Preterm Birth Working Group. Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data. 2016; 34(49):6047-56.
  10. VandenBosche RC, Kirchner JTJAfp. Intrauterine growth retardation. 1998; 58(6):1384.
  11. Maslovich MM, Burke LM. Intrauterine fetal demise. StatPearls [Internet]: StatPearls Publishing; 2021.
  12. Fernández-Carrocera LA, Flores-Tamez E, Salinas-Ramírez V, Bravo-Cabrera Z, Venta-Sobero J, Udaeta-Mora E, Ugartechea JC, Lozano-González CH. The Apgar score as a predictor of neurologic sequellae. 1989; 46(8):554-8.
  13. Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJJAjoo, gynecology. Coronavirus disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. 2020; 222(5):415-26.
  14. Gurol-Urganci I, Jardine JE, Carroll F, Draycott T, Dunn G, Fremeaux A, Harris T, Hawdon J, Morris E, Muller P, Waite L, Webster K, Meulen Jvd, Khalil A. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study. 2021; 225(5):522. e1-. e11.
  15. Sertel E, Demir MJJoO, Research G. Evaluation of the effects of COVID‐19 disease and the trimester in which the disease is diagnosed on obstetric and neonatal outcomes: A retrospective cohort study. 2023; 49(2):614-24.
  16. Kuriloff M, Patel E, Mueller A, Dada T, Duncan C, Arnolds D, Rana S. COVID-19 and obstetric outcomes: a single-center retrospective experience in a predominantly Black population. 2023; 36(1):2196364.
  17. Blencowe H, Cousens S, Chou D, Oestergaard M, Say L, Moller A-B, Kinney M, Lawn J, Born Too Soon Preterm Birth Action Group. Born too soon: the global epidemiology of 15 million preterm births. 2013; 10(1):1-14.
  18. Roumandeh N, Saremi A, Nateghi MR, Zare AJSJoMr. Pregnancy and COVID-19–With a Guideline. 2021; 6(2):94-102.
  19. William W, KONG CWJHKJoG, Obstetrics, Midwifery. Pregnancy outcomes after SARS-CoV-2 infection: the current evidence. 2023; 23(1).
  20. Smith LH, Dollinger CY, VanderWeele TJ, Wyszynski DF, Hernández-Díaz SJBP, Childbirth. Timing and severity of COVID-19 during pregnancy and risk of preterm birth in the International Registry of Coronavirus Exposure in Pregnancy. 2022; 22(1):775.
  21. Fallach N, Segal Y, Agassy J, Perez G, Peretz A, Chodick G, Gazit S, Patalon T, Tov AB, Goldshtein I. Pregnancy outcomes after SARS-CoV-2 infection by trimester: A large, population-based cohort study. 2022; 17(7):e0270893.
  22. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, Li J, Zhao D, Xu D, Gong Q, Liao J, Yang H, Hou W, Zhang Y. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. 2020; 395(10226):809-15.
  23. Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G, Xia S, Zhou W. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. 2020; 9(1):51.
  24. Gomez UT, Francisco RPV, Baptista FS, Gibelli MAB, Ibidi SM, Carvalho WBd, Paganoti CdF, Sabino EC, Oliveira da Silva LCd, Jaenisch T, Mayaud P, Brizot MdL, HC-FMUSP-Obstetric COVID-19 Study Group. Impact of SARS-CoV-2 on pregnancy and neonatal outcomes: An open prospective study of pregnant women in Brazil. 2022; 77.
  25. Sacinti K, Kalafat E, Sukur Y, Koc AJUiO, Gynecology. Increased incidence of first‐trimester miscarriage during the COVID‐19 pandemic. 2021; 57(6):1013.
  26. Cosma S, Carosso AR, Cusato J, Borella F, Carosso M, Bovetti M, Filippini C, D'Avolio A, Ghisetti V, Perri GD, Benedetto C. Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients. 2021; 224(4):391. e1-. e7.
  27. Fung CMJFiN. Effects of intrauterine growth restriction on embryonic hippocampal dentate gyrus neurogenesis and postnatal critical period of synaptic plasticity that govern learning and memory function. 2023; 17:1092357.
  28. Hamidi OP, Lijewski V, Sheeder J, Powell K, Dolph E, Quayson D, Reeves S. Adverse perinatal outcomes in pregnancies affected by severe COVID-19 infection. 2022; 2(4):100118.
  29. Rizzo G, Mappa I, Maqina P, Bitsadze V, Khizroeva J, Makatsarya A, D'Antonio F. Effect of SARS‐CoV‐2 infection during the second half of pregnancy on fetal growth and hemodynamics: a prospective study. 2021; 100(6):1034-9.
  30. Obata S, Matsumoto R, Kakinoki M, Tsuji S, Murakami T, Yanagi T, Maruo Y, Ohji M. Changes in fetal growth restriction and retinopathy of prematurity during the coronavirus disease 2019 pandemic: A cross-sectional study. 2022; 17(3):e0265147.
  31. Jeong Y, Kim M-AJKJoO, Gynecology. SARS-CoV-2 infection in pregnancy and adverse pregnancy outcomes: a systematic review and meta-analysis. 2023.

    disease 2019 in pregnancy: living systematic review and meta-analysis. 2020; 370.

    1. DeSisto CL, Wallace B, Simeone RM, Polen K, Ko JY, Meaney-Delman D, Ellington SR. Risk for stillbirth among women with and without COVID-19 at delivery hospitalization—United States, March 2020–September 2021. 2021; 70(47):1640.
    2. Han Y, Ma H, Suo M, Han F, Wang F, Ji J, Ji J, Ji J, Yang H. Clinical manifestation, outcomes in pregnant women with COVID-19 and the possibility of vertical transmission: a systematic review of the current data. 2020; 48(9):912-24.
    3. Ali Khan M, Khan M, Mustagir M, Rana J, Haque M, Rahman M. COVID-19 infection during pregnancy: a systematic review to summarize possible symptoms, treatments, and pregnancy outcomes. MedRxiv [Preprint]. 2020 [cited 26.07. 2022]: [25 p.].
    4. Irwinda R, Aziz MA, Akbar MIA, Budayasa AAGR, Bernolian N, Dewantiningrum J, et al. The Association of COVID-19 Severity with Laboratory Parameters, Radiologic Findings, Maternal and Neonatal Outcomes in Pregnant Women: A Multicenter Study in Indonesia. 2023; 15(2):189-95.
    5. American College of Obstetriciansand Gynecologists.COVID-19FAQS for obstetrictan-Gynecologists,Obstetrics (Access Date: july 13,2021) [Available from:
    6. Stephansson O, Pasternak B, Ahlberg M, Hervius Askling H, Aronsson B, Appelqvist E, Jonsson J, Sengpiel V, Söderling J, Norman M, Ludvigsson JF, Neovius M. SARS‐CoV‐2 and pregnancy outcomes under universal and non‐universal testing in Sweden: register‐based nationwide cohort study. 2022; 129(2):282-90.
    7. Diriba K, Awulachew E, Getu EJEjomr. The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal–fetal transmission: a systematic review and meta-analysis. 2020; 25:1-14.
    8. Figueiro-Filho EA, Yudin M, Farine D. COVID-19 during pregnancy: an overview of maternal characteristics, clinical symptoms, maternal and neonatal outcomes of 10,996 cases described in 15 countries. 2020; 48(9):900-11.